Scarica l'app Stockscreener
569.55
0.87%
4.89
Dopo l'orario di chiusura:
569.55
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché IDXX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$564.66
Aprire:
$552.05
Volume 24 ore:
693.74K
Relative Volume:
1.37
Capitalizzazione di mercato:
$45.24B
Reddito:
$4.30B
Utile/perdita netta:
$1.06B
Rapporto P/E:
43.54
EPS:
13.0798
Flusso di cassa netto:
$1.04B
1 W Prestazione:
-0.65%
1M Prestazione:
-10.55%
6M Prestazione:
-10.14%
1 anno Prestazione:
+33.62%
Intervallo 1D:
$548.56
$575.42
Intervallo di 1 settimana:
$548.51
$576.87
Portata 52W:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Nome
Idexx Laboratories Inc
Settore
Industria
Telefono
(207) 556-0300
Indirizzo
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
569.55 | 45.24B | 4.30B | 1.06B | 1.04B | 13.08 |
TMO
Thermo Fisher Scientific Inc
|
491.46 | 182.57B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
191.12 | 135.26B | 24.57B | 3.60B | 5.26B | 5.051 |
A
Agilent Technologies Inc
|
115.48 | 32.63B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.24 | 29.85B | 3.17B | 642.63M | 516.49M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-10-31 | Aggiornamento | Stifel | Hold → Buy |
| 2025-10-01 | Iniziato | UBS | Neutral |
| 2025-08-05 | Reiterato | BTIG Research | Buy |
| 2025-07-01 | Iniziato | Jefferies | Buy |
| 2024-12-02 | Iniziato | Leerink Partners | Outperform |
| 2024-07-25 | Iniziato | BTIG Research | Buy |
| 2024-01-30 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Outperform |
| 2023-12-04 | Aggiornamento | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Downgrade | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Downgrade | Stifel | Buy → Hold |
| 2022-07-21 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-07-12 | Iniziato | Piper Sandler | Overweight |
| 2022-05-05 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-02-08 | Iniziato | Atlantic Equities | Overweight |
| 2021-11-18 | Iniziato | Morgan Stanley | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Outperform |
| 2021-07-12 | Downgrade | Guggenheim | Buy → Neutral |
| 2021-02-17 | Iniziato | Barclays | Overweight |
| 2019-09-09 | Iniziato | Goldman | Neutral |
| 2019-05-23 | Iniziato | Guggenheim | Buy |
| 2018-11-02 | Reiterato | BofA/Merrill | Buy |
| 2018-05-07 | Reiterato | Stifel | Buy |
| 2018-01-16 | Iniziato | Piper Jaffray | Overweight |
| 2017-08-23 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Aggiornamento | CL King | Neutral → Buy |
| 2017-02-03 | Downgrade | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Ripresa | BofA/Merrill | Neutral |
| 2016-08-16 | Reiterato | Stifel | Buy |
| 2016-08-03 | Aggiornamento | Northcoast | Sell → Neutral |
| 2016-07-20 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-19 | Reiterato | Canaccord Genuity | Buy |
| 2016-04-01 | Iniziato | CL King | Neutral |
| 2016-03-21 | Reiterato | Stifel | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2015-10-29 | Reiterato | Stifel | Buy |
| 2015-08-28 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Reiterato | Stifel | Buy |
| 2015-07-23 | Reiterato | Canaccord Genuity | Buy |
Mostra tutto
Idexx Laboratories Inc Borsa (IDXX) Ultime notizie
IDEXX Laboratories, Inc. (IDXX) Stock forecasts - Yahoo Finance UK
Why Idexx Laboratories (IDXX) is a Top Growth Stock for the Long-Term - finance.yahoo.com
Rally Mode: Can IDEXX Laboratories Inc deliver alphaDip Buying & AI Enhanced Market Trend Forecasts - baoquankhu1.vn
IDEXX Laboratories, Inc. (IDXX) Stock Forecasts - Yahoo! Finance Canada
Idexx Laboratories (IDXX) Launches Cancer Detection Panel in UK - GuruFocus
Three Seasons Wealth LLC Has $1.55 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Nisa Investment Advisors LLC Has $29.41 Million Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Announces UK Availability of Cancer Dx Panel for Early Detection of Canine Lymphoma - Business Wire
Can IDEXX Laboratories Inc sustain earnings growthMarket Sentiment Review & Capital Efficient Trading Techniques - baoquankhu1.vn
IDEXX Laboratories (NASDAQ:IDXX) Price Target Lowered to $675.00 at Stifel Nicolaus - MarketBeat
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Cuts Target Price to $675 - 富途牛牛
Spire Wealth Management Boosts IDEXX Laboratories Stock Position - National Today
Spire Wealth Management Raises Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX LABORATORIES INC (NASDAQ:IDXX) Passes the Caviar Cruise Quality Stock Screen - ChartMill
Companion Animal Health Market Forecast 2026-2033 Featuring Strategic Analysis of Agrolabo, Boehringer Ingelheim, Ceva, Elanco, IDEXX Labs and More - Yahoo Finance
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Beacon Investment Advisory Services Inc. - MarketBeat
DAVENPORT & Co LLC Reduces IDEXX Laboratories Stake - National Today
DAVENPORT & Co LLC Sells 1,857 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDXX (IDEXX Laboratories) Net Issuance of Preferred Stock : $0 Mil (TTM As of Dec. 2025) - GuruFocus
IDEXX Laboratories Inc. stock underperforms Friday when compared to competitors - MarketWatch
[ARS] IDEXX LABORATORIES INC /DE SEC Filing - Stock Titan
IDEXX (NASDAQ: IDXX) proxy details 2025 growth, CEO change and key governance votes - Stock Titan
Vanguard disaggregates holdings; IDEXX (NASDAQ: IDXX) shows zero - Stock Titan
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Global X Japan Co. Ltd. - MarketBeat
Riverbridge Partners LLC Sells 5,734 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Tikehau Investment Management's IDEXX Laboratories Inc(IDXX) Holding History - GuruFocus
IDEXX Laboratories Announces Executive Departure and $984,000 Separation Agreement with Nimrata Hunt, PhD - Minichart
IDEXX Laboratories (IDXX) Announces Executive Transition with De - GuruFocus
Idexx Laboratories Announces Executive Departure Amid Strategic Realignment - TipRanks
Idexx Laboratories announces executive departure and separation agreement - investing.com
IDEXX: Nimrata Hunt to Leave EVP Role, Will Serve as Advisor Through July 13, 2026 - TradingView
IDEXX Laboratories (NASDAQ: IDXX) executive Nimrata Hunt plans exit with package - Stock Titan
IDEXX Laboratories Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Nordea Investment Management AB Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
5-Star Stocks Poised to Pop: IDEXX Labs - Yahoo
IDXX (IDEXX Laboratories) Earnings Power Value (EPV) : $121.38 (As of Dec25) - GuruFocus
IDEXX Laboratories stock faces institutional shifts and insider sales amid strong FY2026 guidance - AD HOC NEWS
IDXX (IDEXX Laboratories) Cash Flow from Investing : $-136 Mil (TTM As of Dec. 2025) - GuruFocus
Portfolio Recap: Is IDEXX Laboratories Inc showing insider buyingQuarterly Profit Report & Accurate Buy Signal Alerts - baoquankhu1.vn
Here’s what analysts are saying about IDEXX Laboratories (IDXX) - MSN
IDEXX Laboratories, Inc. $IDXX Shares Acquired by Diversified Trust Co. - MarketBeat
Assenagon Asset Management S.A. Acquires 19,741 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
UBS reiterates Neutral rating on IDEXX Laboratories stock at $730 By Investing.com - Investing.com Canada
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Maintains Target Price $730 - 富途牛牛
Seilern Investment Management Ltd Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Marshall Financial Group LLC Sells 1,936 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Holdings Raised by Congress Asset Management Co. - MarketBeat
Procyon Advisors LLC Buys Shares of 2,905 IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories stock faces valuation scrutiny amid steady animal health demand on NASDAQ - AD HOC NEWS
Pricier vet care: Fewer visits but still many $11,000 surgeries - Fortune
Idexx Laboratories Inc Azioni (IDXX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.82%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):